These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9777974

  • 21. A review of nonclinical toxicology studies of becaplermin (rhPDGF-BB).
    Knight EV, Oldham JW, Mohler MA, Liu S, Dooley J.
    Am J Surg; 1998 Aug; 176(2A Suppl):55S-60S. PubMed ID: 9777973
    [Abstract] [Full Text] [Related]

  • 22. A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers.
    Mustoe TA, Cutler NR, Allman RM, Goode PS, Deuel TF, Prause JA, Bear M, Serdar CM, Pierce GF.
    Arch Surg; 1994 Feb; 129(2):213-9. PubMed ID: 8304833
    [Abstract] [Full Text] [Related]

  • 23. Use of Regranex gel for diabetic foot ulcers.
    Piascik P.
    J Am Pharm Assoc (Wash); 1998 Feb; 38(5):628-30. PubMed ID: 9782698
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of chronic ulcers in the lower extremities with topical becaplermin gel .01%: a multicenter open-label study.
    Guzman-Gardearzabal E, Leyva-Bohorquez G, Salas-Colín S, Paz-Janeiro JL, Alvarado-Ruiz R, García-Salazar R.
    Adv Ther; 2000 Feb; 17(4):184-9. PubMed ID: 11185057
    [Abstract] [Full Text] [Related]

  • 25. [Experimental study on recombinant human platelet-derived growth factor gel in a diabetic rat model of cutaneous incisal wound healing].
    Sun TZ, Fu XB, Zhao ZL, Chen W, Sun XQ, Zhou G, Shen ZY.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Oct; 15(10):596-9. PubMed ID: 14552680
    [Abstract] [Full Text] [Related]

  • 26. The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data.
    Persson U, Willis M, Odegaard K, Apelqvist J.
    Value Health; 2000 Oct; 3 Suppl 1():39-46. PubMed ID: 16464208
    [Abstract] [Full Text] [Related]

  • 27. Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers.
    Kallianinen LK, Hirshberg J, Marchant B, Rees RS.
    Plast Reconstr Surg; 2000 Nov; 106(6):1243-8. PubMed ID: 11083552
    [Abstract] [Full Text] [Related]

  • 28. Platelet-rich plasma: support for its use in wound healing.
    Lacci KM, Dardik A.
    Yale J Biol Med; 2010 Mar; 83(1):1-9. PubMed ID: 20351977
    [Abstract] [Full Text] [Related]

  • 29. Effect of platelet-derived growth factor-BB on bone formation in calvarial defects: an experimental study in rabbits.
    Vikjaer D, Blom S, Hjørting-Hansen E, Pinholt EM.
    Eur J Oral Sci; 1997 Feb; 105(1):59-66. PubMed ID: 9085030
    [Abstract] [Full Text] [Related]

  • 30. Re: Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers.
    Brown GL.
    Ann Plast Surg; 1993 Feb; 30(2):192. PubMed ID: 8489189
    [No Abstract] [Full Text] [Related]

  • 31. Platelet derived growth factor-BB levels in gingival crevicular fluid of localized intrabony defect sites treated with platelet rich fibrin membrane or collagen membrane containing recombinant human platelet derived growth factor-BB: A randomized clinical and biochemical study.
    Joshi AA, Padhye AM, Gupta HS.
    J Periodontol; 2019 Jul; 90(7):701-708. PubMed ID: 30637748
    [Abstract] [Full Text] [Related]

  • 32. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent.
    Agren MS, Steenfos HH, Dabelsteen S, Hansen JB, Dabelsteen E.
    J Invest Dermatol; 1999 Apr; 112(4):463-9. PubMed ID: 10201530
    [Abstract] [Full Text] [Related]

  • 33. Diabetic foot ulcers treated with becaplermin and TheraGauze, a moisture-controlling smart dressing: a randomized, multicenter, prospective analysis.
    Landsman A, Agnew P, Parish L, Joseph R, Galiano RD.
    J Am Podiatr Med Assoc; 2010 Apr; 100(3):155-60. PubMed ID: 20479444
    [Abstract] [Full Text] [Related]

  • 34. Transfer of platelet-derived growth factor-BB gene by gene gun increases contraction of collagen lattice by fibroblasts in diabetic and non-diabetic human skin.
    Kuwahara H, Mitchell AT, Macklin MD, Zhao J, Listengarten D, Phillips LG.
    Scand J Plast Reconstr Surg Hand Surg; 2000 Dec; 34(4):301-7. PubMed ID: 11195866
    [Abstract] [Full Text] [Related]

  • 35. Platelet-derived growth factor-BB accelerates wound closure in a new mesentery culture model without macrophages.
    Wu L, Kumar SB, Porras-Reyes BH, Gramates PH, Mustoe TA.
    Ann Plast Surg; 1994 Aug; 33(2):155-61. PubMed ID: 7979047
    [Abstract] [Full Text] [Related]

  • 36. Human plasma fibronectin potentiates the mitogenic activity of platelet-derived growth factor and complements its wound healing effects.
    Larivière B, Rouleau M, Picard S, Beaulieu AD.
    Wound Repair Regen; 2003 Aug; 11(1):79-89. PubMed ID: 12581430
    [Abstract] [Full Text] [Related]

  • 37. Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers.
    Sibbald RG, Torrance G, Hux M, Attard C, Milkovich N.
    Ostomy Wound Manage; 2003 Nov; 49(11):76-84. PubMed ID: 14652415
    [Abstract] [Full Text] [Related]

  • 38. A fragment of secreted Hsp90α carries properties that enable it to accelerate effectively both acute and diabetic wound healing in mice.
    Cheng CF, Sahu D, Tsen F, Zhao Z, Fan J, Kim R, Wang X, O'Brien K, Li Y, Kuang Y, Chen M, Woodley DT, Li W.
    J Clin Invest; 2011 Nov; 121(11):4348-61. PubMed ID: 22019588
    [Abstract] [Full Text] [Related]

  • 39. Growth factors and chronic wound healing: past, present, and future.
    Goldman R.
    Adv Skin Wound Care; 2004 Nov; 17(1):24-35. PubMed ID: 14752324
    [Abstract] [Full Text] [Related]

  • 40. Influence of platelet-derived growth factor on microcirculation during normal and impaired wound healing.
    Uhl E, Rösken F, Sirsjö A, Messmer K.
    Wound Repair Regen; 2003 Nov; 11(5):361-7. PubMed ID: 12950640
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.